UKH Linz revolutionizes heel leg treatment - painless after op!

UKH Linz revolutionizes heel leg treatment - painless after op!

Linz, Österreich - in Linz, a new benchmark is currently being set in the treatment of heel fractures. The University Hospital Linz (UKH) has developed an innovative heel legistor actor that could revolutionize the care of these often complex injuries. The idea for this device came up eight years ago by Dr. Christian Rodemund, and after extensive laboratory tests and a strict approval process, the device is now ready for use in clinical practice. According to OTS , the distributor aims to standardize the operation methods and thus the efficiency as well as the results for the patients considerably improve.

heeling fractures make up about 2% of all broken bones and are often intra-articular, multi-fragmentary or combinated, which makes treatment particularly challenging. Traditionally, there are various treatment methods to choose from in such injuries, such as concentration approaches, as well as open reduction and internal fixation (Orif). But as pmc , standardized protocols are still missing, which often makes treatment a delicate matter.

optimization through minimally invasive techniques

An important advantage of the new distributor is that it is part of a minimally invasive treatment concept that is already used in several Austrian hospitals. Prim. Dr. Georg Mattiassich emphasizes that this modern approach can significantly reduce the risk of wound complications-studies show that the modified minimally invasive technology has a wound complication rate of only 2.7% in many cases increases the risk of up to 16.7%. Early surgery, ideally within three days of the injury, is crucial for the success of the treatment, even with heavily swollen tissue.

An outstanding example of the success of this new method is the patient Christoph Speiser, who, after a severe rubble fracture of the heel, could be operated on thanks to the new distributor and is now painless. Such positive results show how the commitment of the UKH Linz and AUVA pay off in traumatology. In addition, the return rates of patients in professional and sporting activities are high after treatment and are proven by scientific studies.

The future of heeling

The development of the distributor was implemented in cooperation with PMU Innovations GmbH and represented a decisive progress in medical technology. Important support in the initial phase came from the AUVA, which made it possible to apply and test the device clinically. The results could make a decisive contribution to the fact that fewer patients must have persistent symptoms in the future.

With this new technology, the UKH Linz not only sets new standards in the treatment of heel fractures, but also shows how medical innovations can be used in the service of the patient. A look into the future promises hope for even better treatment options and quality of life for those affected.